Drug Shortage Report for CAVERJECT STERILE POWDER
| Report ID | 42319 |
| Drug Identification Number | 02215756 |
| Brand name | CAVERJECT STERILE POWDER - KIT 23.2MCG/VIAL |
| Common or Proper name | Caverject |
| Company Name | PFIZER CANADA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | WATER ALPROSTADIL |
| Strength(s) | 99.1% 23.2MCG |
| Dosage form(s) | KIT LIQUID POWDER FOR SOLUTION |
| Route of administration | INTRACAVERNOSAL |
| Packaging size | 5 x 20MCG |
| ATC code | G04BE |
| ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2018-04-20 |
| Estimated end date | |
| Actual end date | 2018-06-01 |
| Shortage status | Resolved |
| Updated date | 2018-06-04 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
| Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2018-03-08 | English | Compare |
| v2 | 2018-03-08 | English | Compare |
| v3 | 2018-03-08 | French | Compare |
| v4 | 2018-03-08 | English | Compare |
| v5 | 2018-03-08 | French | Compare |
| v6 | 2018-04-19 | English | Compare |
| v7 | 2018-04-20 | English | Compare |
| v8 | 2018-04-20 | French | Compare |
| v9 | 2018-04-21 | English | Compare |
| v10 | 2018-06-04 | English | Compare |
| v11 | 2018-06-04 | French | Compare |
Showing 1 to 11 of 11